Demystifying Ozempic® Doses: How Many Doses in Ozempic® 1mg Pens and Beyond

Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic® pens are designed to deliver semaglutide in a stepwise dosing schedule that begins low and increases gradually over 16 weeks to minimize side effects and optimize results. Each pen contains multiple injections rather than a single dose, making it a convenient delivery system for long-term therapy. Understanding how many doses come in each pen and how the progression works helps patients set realistic expectations for their treatment timeline.

How Many Injections Are in an Ozempic® 1mg Pen

An Ozempic® pen labeled as 1mg does not contain one injection. Instead, a 1mg Ozempic® pen holds enough medication for four separate weekly injections of 0.25mg each. The pen's mechanism allows users to dial their desired dose and administer it through a needle, then store the pen until the following week's injection. This multi-dose design means one pen covers an entire month of treatment during the early phase of therapy.

The total volume in a standard Ozempic® pen is 3mL, which contains the labeled 1mg of semaglutide distributed across multiple uses. As patients progress through their dose escalation schedule, the number of pens required increases because higher doses use more medication per injection. By the time patients reach maintenance doses of 1mg weekly, they will need one pen every four weeks, but during titration phases with lower weekly doses, a single pen may last longer.

Understanding the Standard Semaglutide Dose Escalation Schedule

Semaglutide therapy follows a 16-week titration protocol designed to allow the body to adapt gradually and reduce gastrointestinal side effects. Week 1-4 patients inject 0.25mg weekly, which is the starting dose that helps the body adjust to GLP-1 signaling. Weeks 5-8 increase to 0.5mg weekly, and weeks 9-12 move to 0.75mg weekly. Weeks 13-16 reach the standard 1mg weekly dose, which many patients maintain for ongoing weight loss and metabolic benefits.

This step-wise progression means that during the first month alone, patients use only one-quarter of a pen's capacity with their 0.25mg weekly injections. The escalation continues gradually to help the digestive system acclimate, reducing nausea and other adjustment-related discomfort. Some patients benefit from staying at intermediate doses longer, while others advance on schedule. PlexusDx providers assess individual tolerance and genetic predisposition through the Precision Peptide Genetic Test to personalize dosing timelines.

Comparing Ozempic® Pens to Compounded Semaglutide Injections

Brand-name Ozempic® pens require insurance coverage or significant out-of-pocket costs, with many patients paying hundreds of dollars per pen at retail prices. PlexusDx offers compounded semaglutide injections from licensed 503A compounding pharmacies at a flat rate of $189 per month, with no flat per-compound pricing increases as therapy advances. The clinical formulation is identical in active ingredient, but the delivery model and accessibility differ substantially. PlexusDx serves all 50 states, requires no insurance, and accepts HSA and FSA funds for additional savings.

Compounded semaglutide from PlexusDx follows the same evidence-based dosing schedule as brand-name formulations, ensuring patients receive the correct titration sequence regardless of source. Many patients find that compounded options provide identical therapeutic outcomes while eliminating insurance barriers and unpredictable costs. The Precision Peptide Genetic Test add-on ($298) helps identify whether a patient's genetic profile suggests stronger GLP-1 receptor responsiveness or other peptide-pathway factors that may influence dose timing and medication choice.

Planning Your Treatment Timeline and Medication Supply

Patients starting semaglutide should expect their first pen to last longer than four weeks because the initial doses use less medication per injection. A single 1mg pen at 0.25mg weekly provides four injections, covering four weeks of the starting phase. When the dose increases to 0.5mg weekly during weeks 5-8, the same pen structure still delivers four injections, but each uses twice as much medication. This means transitioning between pens may occur mid-week or mid-month depending on individual timing, so coordination with your provider ensures uninterrupted therapy.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

How many weeks does one Ozempic® 1mg pen last?

A 1mg Ozempic® pen contains four 0.25mg doses, covering exactly four weeks during the first month of treatment. As doses increase during titration, the same pen structure still provides four injections but uses more medication per injection, so the pen duration decreases. By the maintenance phase at 1mg weekly, one pen lasts exactly four weeks. PlexusDx compounded semaglutide follows identical dosing schedules with the same injection intervals.

What happens if I run out of semaglutide mid-week?

Skipping a single weekly injection typically does not cause harm, but missing doses interrupts the medication's appetite-suppressing effects and may reduce weight loss effectiveness. Coordination with your PlexusDx provider ensures prescription refills align with your injection schedule. The flat monthly pricing model allows patients to order refills proactively without worrying about dose-based cost surprises, helping maintain consistent treatment adherence.

Why does PlexusDx offer compounded semaglutide at $189/month when brand Ozempic® costs more?

PlexusDx partners with licensed 503A compounding pharmacies to provide pharmaceutical-grade semaglutide without brand-name markup or insurance middleman costs. The flat-rate pricing structure eliminates dose-based billing, meaning your price remains $149/month whether you're at 0.25mg or 1mg weekly. This model prioritizes access and affordability while maintaining clinical quality and safety standards.

Are there side effects from advancing doses too quickly?

Rapid dose escalation increases gastrointestinal side effects like nausea, vomiting, and constipation because the body needs time to acclimate to GLP-1 receptor activation. The standard 16-week titration schedule was designed through clinical trials to balance efficacy with tolerability. PlexusDx providers can adjust your escalation timeline based on symptom tolerance and genetic insights from the Precision Peptide Genetic Test, which identifies whether your GIPR variants suggest faster or slower dose progression.

How does the Precision Peptide Genetic Test help with semaglutide dosing?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.